Cambridge biotechnology firm Tceb Limited raises £195.2k

Research and experimental development on biotechnology is the primary focus of Tceb Limited. Based in Cambridge, the company operates across the healthcare and life-science sectors and has recently secured an estimated £195.2k in new funding.

This latest capital injection brings the total funding raised by the firm throughout 2026 to £505.1k. During the previous calendar year of 2025, the business successfully brought in £1.8m in capital.

The company was incorporated in 2023 and operates with a single employee according to its latest financial accounts. These records cover the period ending 30 June 2025. Share allotment for the current round took place in July 2026. Formal documentation for the investment was filed during the same month.